First Command Financial Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-56
Closed -$7K 437
2021
Q4
$7K Buy
+56
New +$6.53K ﹤0.01% 384
2020
Q1
Sell
-960
Closed -$75K 351
2019
Q4
$75K Hold
960
0.04% 180
2019
Q3
$70K Hold
960
0.04% 185
2019
Q2
$59K Buy
+960
New +$58K 0.03% 189
2019
Q1
Sell
-1,800
Closed -$92K 424
2018
Q4
$92K Buy
+1,800
New +$91.1K 0.05% 158
2017
Q3
Sell
-600
Closed -$24K 415
2017
Q2
$24K Buy
+600
New +$21.9K 0.02% 276

Other funds holding EW

First Command Financial Services's EW Position: Q1 2022 in Review

First Command Financial Services sold out of Edwards Lifesciences (EW) in Q1 2022, closing a stake of 56 shares — an estimated $7K sold.

First Command Financial Services first reported a position in EW in Q2 2017 and held it in 6 quarters. The position peaked at $92K in Q4 2018. 1,312 funds tracked by Wall St. Rank hold EW as of Q1 2022.

  • First Command Financial Services reported no remaining Edwards Lifesciences position as of Q1 2022 after selling out during the quarter.
  • First Command Financial Services sold 56 Edwards Lifesciences shares in Q1 2022, an estimated $7K.
  • First Command Financial Services first reported a position in Edwards Lifesciences in Q2 2017 and held it in 6 quarters.
  • First Command Financial Services's Edwards Lifesciences position peaked at $92K in Q4 2018.
  • 1,312 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.

Based on First Command Financial Services's 13F filing for Q1 2022, filed 14 Apr 2022.